DLHCX
Price
$24.56
Change
-$0.19 (-0.77%)
Updated
Nov 19 closing price
Net Assets
704.16M
FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
Interact to see
Advertisement

DLHCX vs FSPHX

Header iconDLHCX vs FSPHX Comparison
Open Charts DLHCX vs FSPHXBanner chart's image
Macquarie Healthcare C
Price$24.56
Change-$0.19 (-0.77%)
VolumeN/A
Net Assets704.16M
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
DLHCX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
DLHCX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. DLHCX (704M). FSPHX pays higher dividends than DLHCX: FSPHX (0.02) vs DLHCX (0.00). DLHCX was incepted earlier than FSPHX: DLHCX (16 years) vs FSPHX (44 years). DLHCX (2.01) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLHCX (5.00). FSPHX has a lower initial minimum investment than DLHCX: FSPHX (0) vs DLHCX (1000). DLHCX annual gain was more profitable for investors over the last year : 2.04 vs. FSPHX (0.02). DLHCX return over 5 years is better than : -6.93 vs. FSPHX (-8.84).
DLHCXFSPHXDLHCX / FSPHX
Total Expense Ratio1.960.63311%
Annual Report Gross Expense Ratio2.010.63319%
Fund Existence16 years44 years-
Gain YTD17.06410.532162%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets704M6.22B11%
Annual Yield % from dividends0.000.02-
Returns for 1 year2.040.0212,043%
Returns for 3 years-0.8110.47-8%
Returns for 5 years-6.93-8.8478%
Returns for 10 years23.0839.3459%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5